Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

Re: Reboxetrine

Posted by Terry on March 14, 1999, at 21:18:06

In reply to Reboxetrine, posted by Mr. Steve on March 14, 1999, at 17:06:58

Mr. Steve -- the last I heard, reboxetine (Edronax)was still being studied in the U.S., but that was in late 1997. At that time, the company said it expected it to be approved in 1999. It's possible it is being reviewed by FDA at this point. Reboxetine is the first of a new class of antidepressants referred to as "selective noradrenaline reuptake inhibitors" (NARIs). It supposedly has fewer side effects than other antidepressants. It is also supposed to be especially effective against severe depression. It's approved in the U.K. and 11 other European countries, so that should help move it along the approval process here. For more information, contact the drug's manufacturer, Pharmacia & Upjohn in NJ. 908-306-4400 or They may tell you the status of the drug at the FDA. Terry

> Does anyone know when this med will be available in the U.S.?




Post a new follow-up

Your message only Include above post

Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.


Start a new thread

Google www
Search options and examples
[amazon] for

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:Terry thread:3688